Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US - 360Dx

Biodesix to Acquire Oncimmune Operations, Lung Cancer Test in US  360Dx

NEW YORK — Biodesix said today that it has signed an agreement to acquire Oncimmune's US operations and the US rights to the firm's blood-based incidental ...



Comments

Popular posts from this blog

Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic ...

Stage 4 Lung Cancer Life Expectancy

A Review of the Etiology and Epidemiology of Bladder Cancer: All ...